This article ran on Monday, Feb. 23, 2026. On Wednesday, Feb. 25, 2026, Tandem announced the upsized pricing of the offering. Read the updated article here. Tandem Diabetes Care (Nasdaq:TNDM) announced today that it intends to offer $200 million in convertible senior notes, due in 2032. San Diego-based Tandem said it plans to offer […]
Drug-Device Combinations
Medtronic Diabetes to lay off 81 employees ahead of MiniMed separation
Medtronic (NYSE:MDT) is cutting 81 jobs from its Diabetes unit ahead of its planned separation into MiniMed. A Worker Adjustment and Retraining Notification (WARN) notice filed in California confirms the company’s plans to lay off 81 employees at its Northridge facility. MedTech Dive reported the news first. The notice states that Medtronic notified the state of the […]
ICU Medical resolves Smiths Medical warning letter, posts mixed Q4
ICU Medical (Nasdaq:ICUI) shares dipped slightly today on fourth-quarter results that were mixed compared to the consensus forecast. Shares of ICUI fell 1.25% to $149.74 apiece in early-morning trading today. The San Clemente, California-based infusion technology and critical care product provider reported losses of $15.7 million. That equals 64¢ per share on sales of $540.7 […]
Tandem stock rises on Q4 beats, new pay-as-you-go model
Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast. Shares of TNDM rose 11.5% to $20.65 apiece after the market closed today. The San Diego-based automated insulin delivery technology developer reported losses of 589 million. That equals 1¢ per share on sales of $290.4 […]
MGS opens new drug delivery device manufacturing facility
MGS has brought a 300,000 square foot drug delivery device manufacturing facility online in Richfield, Wisconsin. The medtech CDMO’s newest facility expands U.S. production capacity as demand for complex combination products strains available cleanroom capacity. MGS said it developed the facility to support an unnamed global pharmaceutical company’s drug delivery platform. The site has 140,000 square […]
Sequel, Senseonics announce full launch of Eversense 365 CGM, twiist pump pairing
Sequel Med Tech and Senseonics (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration. Manchester, New Hampshire-based Sequel and Germantown, Maryland-based Senseonics now offer the Eversense 365 continuous glucose monitor (CGM) with the twiist automated insulin delivery (AID) system for people with type 1 diabetes in the U.S. The companies […]
InVera Medical wins European approval for vein infusion device
InVera Medical announced recently that it picked up European approval for its minimally invasive device for delivering vein treatments. The Galway, Ireland-based company designed its device to help deliver treatment more effectively to diseased leg veins, including varicose veins. CE mark approval enables the marketing of the InVera Infusion Device across the European Union. According […]
Insulet stock rises before hours on Street-beating Q4, 31% sales growth
Insulet (Nasdaq:PODD) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast. Shares of PODD ticked up more than 8% to $266.10 apiece in morning trading today. The Acton, Massachusetts–based automated insulin delivery technology developer reported profits of $101.6 million. That equals $1.44 per share on sales of $783.8 […]
Beta Bionics sales grow 57% in Street-beating Q4, guidance set for 2026
Beta Bionics (Nasdaq:BBNX) shares rose slightly after hours today on fourth-quarter results that topped the consensus forecast. Shares of BBNX ticked up about 1% to $14.10 apiece in post-market trading today. The Irvine, California-based automated insulin delivery system developer reported losses of $13.5 million. That equals 38¢ per share on sales of $32.1 million for […]
Medtronic submits MiniMed Flex to FDA, Diabetes separation is on track amid strong Q4
Medtronic (NYSE:MDT) said today that the separation of its MiniMed Diabetes unit remains on track as it advances the MiniMed Flex system. On the company’s third-quarter earnings call, CFO Thierry Piéton explained the business’ performance as it works toward completing an IPO — for which it filed at the end of 2025 — and bringing […]









